세계의 AAV 수탁 개발 및 제조기관 시장 : 워크플로우별, 배양유형별, 치료영역별, 방법별, 용도별, 최종사용자별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

REPORT HIGHLIGHT

AAV Contract Development and Manufacturing Organizations Market size was valued at USD 677.56 Million in 2023, expanding at a CAGR of 16.9% from 2024 to 2032.

Adeno-associated viruses (AAVs) are small, non-pathogenic viruses famous for their utility as vectors in gene therapy and biomedical research. They are characterized by their ability to infect cells and deliver genetic material without causing disease in humans. AAV vectors are increasingly being used in the clinic to treat a wide range of diseases and tissues such as Parkinson's disease and Peripheral nerve regeneration.

AAV Contract Development and Manufacturing Organizations Market- Market Dynamics

Increasing gene therapy trials elevate AAV vector requirements.

The global market for viral vector Contract Development and Manufacturing Organizations (CDMOs) is poised for significant growth in the coming years, driven by advancements in gene therapy and increasing investments by governments and leading market players. This growth is primarily fueled by rising demand for adeno-associated virus (AAV) vectors in gene therapy R&D, highlighting the pivotal role played by AAV CDMOs in their production and manufacturing.

Government investments in innovative technologies and manufacturing facilities further contribute to market expansion. Novel technologies such as automation, cloud computing, industrial robotics, artificial intelligence, and the Internet of Things are making manufacturing processes more efficient. Adeno-associated virus (AAV) CDMOs provide specialized expertise and infrastructure crucial for supporting the biopharmaceutical industry, ensuring efficient production of AAV vectors to meet the growing demand. With these factors in play, the AAV CDMOs market is set to witness robust growth throughout the forecast period, driven by the increasing adoption of gene therapy and advancements in biopharmaceutical manufacturing.

AAV Contract Development and Manufacturing Organizations Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.9% over the forecast period (2024-2032)

Based on Workflow segmentation, Downstream Processing was predicted to show maximum market share in the year 2023

Based on Culture Type segmentation, Adherent Culture was the leading type in 2023

Based on Therapeutic Area segmentation, Neurological disorders were the leading type in 2023

Based on the Method, in vivo was the leading type in 2023

Based on Application, Cell & Gene Therapy was the leading type in 2023

Based on End User segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

AAV Contract Development and Manufacturing Organizations Market- Segmentation Analysis:

The Global AAV Contract Development and Manufacturing Organizations Market is segmented based on Workflow, Culture Type, Therapeutic Area, Method, Application, End User, and Region.

The market is divided into two categories based on Workflow: Upstream Processing and Downstream Processing. Downstream processing refers to the purification, concentration, and formulation steps involved in isolating and refining AAV vectors after they have been produced in cell culture. This includes processes such as cell lysis, clarification, chromatography (e.g., affinity chromatography, ion exchange chromatography), filtration, and formulation. The dominance of downstream processing in the AAV vector sector is due to the critical need to purify and concentrate AAV vectors to achieve high-purity and high-titer vector preparations suitable for clinical use. Downstream processing ensures that AAV vectors are free from contaminants and impurities, maintain stability, and are formulated in a manner that enhances their safety, efficacy, and storage stability.

The market is divided into four categories based on Culture Type: Adherent culture and Suspension Adherent cultures involve growing cells that attach to a treated surface, forming a single layer. This method is ideal for studying animal cells but limits them to a flat, 2D environment, unlike their natural form. While useful for various applications, adherent cultures can be limited in terms of scalability due to their surface area dependence.

AAV Contract Development and Manufacturing Organizations Market- Geographical Insights

The AAV gene therapy sector is experiencing significant growth in North America, driven by several key factors. Firstly, the region hosts a substantial number of research centers and institutes dedicated to advancing gene therapy technologies. These institutions play a pivotal role in conducting cutting-edge research and development and fostering innovation in AAV vector technologies and therapeutic applications. Their collective efforts contribute to the robust pipeline of novel therapies targeting a wide range of genetic disorders, neurodegenerative diseases, and cancers.

Additionally, federal agencies in North America have allocated substantial investments to bolster the local cell and gene therapy research infrastructure.

AAV Contract Development and Manufacturing Organizations Market- Competitive Landscape:

Major players in the market are Thermo Fischer Scientific, Inc., Oxford Biomedica, Charles River Laboratories International, Inc., Creative Biogene, GenScript ProBio, Merck KGaA, Catalent Inc., FUJIFILM Diosynth Biotechnologies, Lonza, Curia Global, Inc., and Takara Bio Inc. These companies, among many others, play a crucial role in advancing and expanding the AAV vector manufacturing market. Their collective efforts underscore their critical contribution to the development of gene therapy and its potential to revolutionize medical treatments.

Recent Developments:

In May 2024, Andelyn Biosciences was selected to manufacture AAV therapies under CIRM, aimed to advance BGTC's mission to develop platforms and standards and propel the development and delivery of customized gene therapies for millions affected with rare diseases.

In Feb 2024, Charles River Laboratories International, Inc. introduced reference materials for its adeno-associated virus (AAV) and lentiviral vector (LVV) portfolio, aimed at enhancing the efficiency of Cell and Gene Therapy (CGT) research and development as it transitions to Good Manufacturing Practice (GMP) standards.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific, Inc.

Catalent Inc.

Charles River Laboratories International, Inc.

Danaher (Aldevron)

Merck KGaA

Biovian Oy

Esco Lifesciences (Esco Aster Pte. Ltd.)

GenScript ProBio

Takara Bio, Inc.

Oxford Biomedica

Belief Biomed, Inc.

Forge Biologics

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032

• Upstream Processing
• Downstream Processing

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY CULTURE TYPE- MARKET ANALYSIS, 2019 - 2032

• Adherent Culture
• Suspension Culture

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

• Neurological disorders
• Metabolic disorders
• Ophthalmic disorders
• Muscular/Neuromuscular disorders
• Infectious diseases
• Bleeding disorders
• Inflammation and fibrosis
• Other therapeutic areas

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

• In vitro
• In vivo

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Cell & Gene Therapy
• Development, Vaccine Development
• Biopharmaceutical & Pharmaceutical
• Discovery, Biomedical Research

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes

GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. AAV Contract Development and Manufacturing Organizations Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. AAV Contract Development and Manufacturing Organizations Market Snippet by Workflow
  • 2.1.2. AAV Contract Development and Manufacturing Organizations Market Snippet by Culture Type
  • 2.1.3. AAV Contract Development and Manufacturing Organizations Market Snippet by Therapeutic Area
  • 2.1.4. AAV Contract Development and Manufacturing Organizations Market Snippet by Method
  • 2.1.5. AAV Contract Development and Manufacturing Organizations Market Snippet by Application
  • 2.1.6. AAV Contract Development and Manufacturing Organizations Market Snippet by End User
  • 2.1.7. AAV Contract Development and Manufacturing Organizations Market Snippet by Country
  • 2.1.8. AAV Contract Development and Manufacturing Organizations Market Snippet by Region
• 2.2. Competitive Insights

3. AAV Contract Development and Manufacturing Organizations Key Market Trends

• 3.1. AAV Contract Development and Manufacturing Organizations Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. AAV Contract Development and Manufacturing Organizations Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. AAV Contract Development and Manufacturing Organizations Market Opportunities
• 3.4. AAV Contract Development and Manufacturing Organizations Market Future Trends

4. AAV Contract Development and Manufacturing Organizations Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. AAV Contract Development and Manufacturing Organizations Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. AAV Contract Development and Manufacturing Organizations Market Landscape

• 6.1. AAV Contract Development and Manufacturing Organizations Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. AAV Contract Development and Manufacturing Organizations Market - By Workflow

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Workflow, 2023 & 2032 (%)
  • 7.1.2. Upstream Processing
  • 7.1.3. Downstream Processing

8. AAV Contract Development and Manufacturing Organizations Market - By Culture Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Culture Type, 2023 & 2032 (%)
  • 8.1.2. Adherent Culture
  • 8.1.3. Suspension Culture Formulation

9. AAV Contract Development and Manufacturing Organizations Market - By Therapeutic Area

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
  • 9.1.2. Neurological disorders
  • 9.1.3. Metabolic disorders
  • 9.1.4. Ophthalmic disorders
  • 9.1.5. Muscular/Neuromuscular disorders
  • 9.1.6. Infectious diseases
  • 9.1.7. Bleeding disorders
  • 9.1.8. Inflammation and fibrosis
  • 9.1.9. Other therapeutic areas

10. AAV Contract Development and Manufacturing Organizations Market - By Method

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Method, 2023 & 2032 (%)
  • 10.1.2. In vitro
  • 10.1.3. In vivo

11. AAV Contract Development and Manufacturing Organizations Market - By Application

• 11.1. Overview
  • 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 11.1.2. Cell & Gene Therapy
  • 11.1.3. Development, Vaccine Development
  • 11.1.4. Biopharmaceutical & Pharmaceutical
  • 11.1.5. Discovery, Biomedical Research

12. AAV Contract Development and Manufacturing Organizations Market - By End User

• 12.1. Overview
  • 12.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
  • 12.1.2. Pharmaceutical & Pharmaceutical Companies
  • 12.1.3. Academic & Research Institutes Others

13. AAV Contract Development and Manufacturing Organizations Market- By Geography

• 13.1. Introduction
  • 13.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 13.2. North America
  • 13.2.1. Overview
  • 13.2.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in North America
  • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 13.2.4. North America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 13.2.5. North America Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
  • 13.2.6. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 13.2.7. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 13.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.2.10. U.S.
    • 13.2.10.1. Overview
    • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.2.10.3. U.S. Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.2.10.4. U.S. Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.2.10.5. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.2.10.6. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.2.10.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.2.11. Canada
    • 13.2.11.1. Overview
    • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.2.11.3. Canada Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.2.11.4. Canada Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.2.11.5. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.2.11.6. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.2.11.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 13.3. Europe
  • 13.3.1. Overview
  • 13.3.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Europe
  • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 13.3.4. Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 13.3.5. Europe Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
  • 13.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 13.3.7. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 13.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.10. Germany
    • 13.3.10.1. Overview
    • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.10.3. Germany Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.10.4. Germany Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.10.5. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.10.6. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.10.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.11. Italy
    • 13.3.11.1. Overview
    • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.11.3. Italy Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.11.4. Italy Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.11.5. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.11.6. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.11.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.12. United Kingdom
    • 13.3.12.1. Overview
    • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.12.3. United Kingdom Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.12.4. United Kingdom Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.12.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.12.6. United Kingdom Market Size and Method, By End User, 2019 - 2032 (US$ Million)
    • 13.3.12.7. United Kingdom Market Size and Application, By End User, 2019 - 2032 (US$ Million)
    • 13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.13. France
    • 13.3.13.1. Overview
    • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.13.3. France Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.13.4. France Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.13.5. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.13.6. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.13.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 13.3.13.9.
  • 13.3.14. Russia
    • 13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.14.2. Russia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.14.3. Russia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.14.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.14.5. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.14.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.15. Netherlands
    • 13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.15.2. Netherlands Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.15.3. Netherlands Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.15.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.15.5. Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.15.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.16. Sweden
    • 13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.16.2. Sweden Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.16.3. Sweden Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.16.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.16.5. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.16.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.17. Poland
    • 13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.17.2. Poland Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.17.3. Poland Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.17.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.17.5. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.3.18. Rest of Europe
    • 13.3.18.1. Overview
    • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.3.18.3. Rest of the Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.3.18.4. Rest of the Europe Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.3.18.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.3.18.6. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.3.18.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.18.8. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 13.4. Asia Pacific (APAC)
  • 13.4.1. Overview
  • 13.4.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Asia Pacific
  • 13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 13.4.4. Asia Pacific Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 13.4.5. Asia Pacific Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
  • 13.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 13.4.7. Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 13.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.10. Inda
    • 13.4.10.1. Overview
    • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.10.3. India Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.10.4. India Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.10.5. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.10.6. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.10.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.11. China
    • 13.4.11.1. Overview
    • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.11.3. China Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.11.4. China Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.11.5. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.11.6. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.11.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.12. Japan
    • 13.4.12.1. Overview
    • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.12.3. Japan Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.12.4. Japan Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.12.5. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.12.6. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million
    • 13.4.12.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million
    • 13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.13. South Korea
    • 13.4.13.1. Overview
    • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.13.3. South Korea Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.13.4. South Korea Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.13.5. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.13.6. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.13.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.14. Australia
    • 13.4.14.1. Overview
    • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.14.3. Australia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.14.4. Australia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.14.5. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.14.6. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.14.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.15. Thailand
    • 13.4.15.1. Overview
    • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.15.3. Thailand Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.15.4. Thailand Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.15.5. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.15.6. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.15.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.16. Indonesia
    • 13.4.16.1. Overview
    • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.16.3. Indonesia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.16.4. Indonesia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.16.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.16.6. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.16.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.17. Philippines
    • 13.4.17.1. Overview
    • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.17.3. Philippines Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.17.4. Philippines Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.17.5. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.17.6. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.17.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.4.18. Rest of APAC
    • 13.4.18.1. Overview
    • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.4.18.3. Rest of APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.4.18.4. Rest of APAC Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.4.18.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.4.18.6. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.4.18.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 13.5. Latin America
  • 13.5.1. Overview
  • 13.5.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Latin America
  • 13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 13.5.4. Latin America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 13.5.5. Latin America Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
  • 13.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 13.5.7. Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 13.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5.10. Brazil
    • 13.5.10.1. Overview
    • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.5.10.3. Brazil Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.5.10.4. Brazil Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.5.10.5. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.5.10.6. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.5.10.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5.11. Mexico
    • 13.5.11.1. Overview
    • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.5.11.3. Mexico Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.5.11.4. Mexico Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.5.11.5. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.5.11.6. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.5.11.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5.12. Argentina
    • 13.5.12.1. Overview
    • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.5.12.3. Argentina Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.5.12.4. Argentina Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.5.12.5. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.5.12.6. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.5.12.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5.13. Colombia
    • 13.5.13.1. Overview
    • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.5.13.3. Colombia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.5.13.4. Colombia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.5.13.5. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.5.13.6. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.5.13.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.5.14. Rest of LATAM
    • 13.5.14.1. Overview
    • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.5.14.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 13.6. Middle East and Africa
  • 13.6.1. Overview
  • 13.6.2. AAV Contract Development and Manufacturing Organizations Key Manufacturers in Middle East and Africa
  • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 13.6.4. Middle East and Africa Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 13.6.5. Middle East and Africa Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
  • 13.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 13.6.7. Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6.10. Saudi Arabia
    • 13.6.10.1. Overview
    • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.6.10.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6.11. United Arab Emirates
    • 13.6.11.1. Overview
    • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.11.6. United Arab Emirates Market Size and Method, By End User, 2019 - 2032 (US$ Million)
    • 13.6.11.7. United Arab Emirates Market Size and Application, By End User, 2019 - 2032 (US$ Million)
    • 13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6.12. Israel
    • 13.6.12.1. Overview
    • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.6.12.3. Israel Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.12.4. Israel Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.12.5. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.12.6. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.6.12.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.12.8. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6.13. Turkey
    • 13.6.13.1. Overview
    • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.6.13.3. Turkey Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.13.4. Turkey Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.13.5. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.13.6. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.6.13.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6.14. Algeria
    • 13.6.14.1. Overview
    • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.6.14.3. Algeria Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.14.4. Algeria Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.14.5. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.14.6. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.6.14.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6.15. Egypt
    • 13.6.15.1. Overview
    • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.6.15.3. Egypt Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.15.4. Egypt Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.15.5. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.15.6. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.6.15.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 13.6.16. Rest of MEA
    • 13.6.16.1. Overview
    • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 13.6.16.3. Rest of MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 13.6.16.4. Rest of MEA Market Size and Forecast, By Culture Type, 2019 - 2032 (US$ Million)
    • 13.6.16.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 13.6.16.6. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
    • 13.6.16.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.16.8. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- AAV Contract Development and Manufacturing Organizations Industry

• 14.1. Competitive Dashboard
• 14.2. Company Profiles
  • 14.2.1. Thermo Fisher Scientific, Inc.
  • 14.2.2. Catalent Inc.
  • 14.2.3. Charles River Laboratories International, Inc.
  • 14.2.4. Danaher (Aldevron)
  • 14.2.5. Merck KGaA
  • 14.2.6. Biovian Oy
  • 14.2.7. Esco Lifesciences (Esco Aster Pte. Ltd.)
  • 14.2.8. GenScript ProBio
  • 14.2.9. Takara Bio, Inc.
  • 14.2.10. Oxford Biomedica
  • 14.2.11. Belief Biomed, Inc.
  • 14.2.12. Forge Biologics

15. 360 Degree Analyst View

16. Appendix

• 16.1. Research Methodology
• 16.2. References
• 16.3. Abbreviations
• 16.4. Disclaimer
• 16.5. Contact Us